Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Leddon, Jennifer
PRESERVE-003, NCT05671510: ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors	Active, not recruiting	3	600	Europe, Canada, US, RoW	Gotistobart, A humanized anti-CTLA4 IgG1 monoclonal antibody, ONC-392, BNT316, Docetaxel, Docefrez, Taxotere	OncoC4, Inc., BioNTech SE	Non Small Cell Lung Cancer	06/26	06/27
KEYNOTE F92, NCT05597839: Study of DF9001 in Patients With Advanced Solid Tumors	Recruiting	1/2	242	US	DF9001, pembrolizumab, KEYTRUDA®	Dragonfly Therapeutics, Merck Sharp & Dohme LLC	Solid Tumor, Adult	08/25	11/27
NEBULA, NCT05043714: Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours Initiation of trial in combination with NG-641 Sep 2021 - Sep 2021: Initiation of trial in combination with NG-641	Active, not recruiting	1	30	Europe, US	NG-641 in combination with Nivolumab	Akamis Bio, Bristol-Myers Squibb	Metastatic Cancer, Epithelial Tumor	08/24	12/24
OASIS, NCT06063317: A Study of OnCARlytics (CF33-CD19) in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors	Recruiting	1	33	US	CF33-CD19 IT, CF33-CD19 IV, Blinatumomab, Blincyto	Imugene Limited	Solid Tumor, Adult	06/27	05/29
MAST, NCT05346484: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors	Recruiting	1	100	US, RoW	CF33-hNIS, VAXINIA, HOV2, Pembrolizumab, KEYTRUDA®	Imugene Limited	Solid Tumor, Solid Carcinoma, Solid Tumor, Adult, Metastatic Cancer, Advanced Solid Tumor, Cholangiocarcinoma, Bile Duct Cancer	12/24	01/25